There are more microbes on earth than stars in the sky
A Shield Against Unseen Microbes That Impact
Well-Being
Antimicrobial Additives Enhance Great Products
The impact of microbes on daily life can range from annoying to dangerous – and there are more species of them here on Earth than there are stars in the galaxy.
Copptech™ is dedicated to improving daily lives around the world with patented antimicrobial technology that can be added to a variety of items. The ways our technology can improve products is limited only by imagination.
Adding Copptech ingredients can improve materials from textiles and footwear to packaging, building materials, irrigation components and more.
Our ingredient technology turns your company’s “goods” into “Good thinking!”
Our Vision
To improve the well-being of people around the world by challenging conventional thinking.
Our Mission
To partner with leading companies across a range of industries and enhance product performance with our proprietary, antimicrobial technology.
Our History
2011-2013
- We partnered with Codelco Lab to find alternative uses of Copper and from this R&D.
- We produced a unique antimicrobial technology based on Copper & Zinc.
2014
- Copptech brand is created. Over 200 products prototype incorporating the technology and brings a subset of those products to the Chilean market.
2016
- Copptech goes through clinical trials for the NHS. The technology proves a 38% reduction in hospital days for C-section patients
- China office is established to provide supply chain and operations support.
2018
- Copptech establishes USA-based business operations
- Successful Series A investment raise
- EPA registrations successful
2020
- Copptech wins UK Global Entrepreneur Program
- Connection to UK-based VC, Foresight Group
2021
- Successful Series B investment raise
- UK HQ Established and consolidation of global team
2022
- Copptech office opens in Mexico
- Expands reach into the Americas
- R&D Hub, UK established
- Additional ingredient portfolio, having +50 solutions available